ScienceChina’s DREADDs human testing shows early promise, startling scientists
A Beijing lab reports that DREADDs treatment reduced seizure frequency by an average of 92.6% in three patients with drug-resistant epilepsy. The study found mild-to-moderate adverse events. A University of Cambridge researcher said viral delivery and possible long-term effects on cells warrant consideration.
C
CGTN★★★☆☆2026-11-06 16:31Original
China’s DREADDs human testing shows early promise, startling scientists
Science